Clinical trial · Interventional
Systematic Intervention to Improve Sexual Dysfunction
Systematic Intervention to Improve Sexual Dysfunction in Adjuvant Breast Cancer Patients
NCT06583460CI-TRIAL-00121838SISTERactive not recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this clinical trial is to compare the benefit of early, systematic, multidisciplinary oncosexological care versus on-demand care on the sexual health of women with breast cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Female | — | UNRESOLVED | — |
| Localized Cancer | Malignant Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Early and systematic oncosexological supporting care | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Breast cancer treatment with oncosexology supporting care
- description
- Patient initially treated by surgery combined with any therapy (chemotherapy, radiotherapy, hormonal therapy etc.) and benefiting oncosexological care.
- interventionNames
- Other: Early and systematic oncosexological supporting care
Primary outcomes (1)
- measure
- Sexual satisfaction
- timeFrame
- Measured at baseline and at 18 months following initiation of treatment and surgical.
- description
- Sexual satisfaction score measured by self-questionnaire using the EORTC Quality of Life Questionnaire Sexual Health scale (EORTC QLQ-SH22).
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Women ≥ 18 years (menopausal or not), * Localized breast cancer with or without lymph node involvement, * Initial treatment starting with surgical resection, whatever the associated therapy (chemotherapy, radiotherapy, hormone therapy, monoclonal antibody, conjugated drug antibody, targeted therapy such as cyclin and anti-PARP inhibitors, etc.), * Patient affiliated or benefiting from the social security system, * Patient informed and informed consent signed. Exclusion Criteria: * History of cancer (except squamous cell carcinoma or basal cell carcinoma) in the last five years, * Pregnant or breast-feeding women, * Patients deprived of their liberty, under guardianship or curatorship and all other administrative safeguards, * Patients unable to comply with the study schedule for social, medical or psychological reasons.
References
Publications (0)
Data not yet available
No reference posted for this study.